首页> 外文OA文献 >Nanotechnological delivery systems for the oral administration ofactive molecules: Polymeric microparticles and microemulsions applied to anti-inflammatory and anti-infectious drugs
【2h】

Nanotechnological delivery systems for the oral administration ofactive molecules: Polymeric microparticles and microemulsions applied to anti-inflammatory and anti-infectious drugs

机译:纳米技术的口服给药系统活性分子:应用于抗炎和抗感染药物的聚合物微粒和微乳状液

摘要

This thesis was devoted to the development of innovative oral delivery systems for twodifferent molecules. In the first part, microparticles (MPs) based on xylan and Eudragit® S-100 were produced and used to encapsulate 5-aminosalicylic acid for colon delivery. Xylanwas extracted from corn cobs and characterized in terms of its physicochemical, rheologicaland toxicological properties. The polymeric MPs were prepared by interfacial cross-linkingpolymerization and spray-drying and characterized for their morphology, mean size anddistribution, thermal stability, crystallinity, entrapment efficiency and in vitro drug release.MPs with suitable physical characteristics and satisfactory yields were prepared by bothmethods, although the spray-dried systems showed higher thermal stability. In general, spraydriedMPs would be preferable systems due to their thermal stability and absence of toxicagents used in their preparation. However, drug loading and release need to be optimized. Inthe second part of this thesis, oil-in-water microemulsions (O/W MEs) based on mediumchaintriglycerides were formulated as drug carriers and solubility enhancers for amphotericinB (AmB). Phase diagrams were constructed using surfactant blends with hydrophiliclipophilicbalance values between 9.7 and 14.4. The drug-free and drug-loaded MEs presentedspherical non-aggregated droplets around 80 and 120 nm, respectively, and a lowpolydispersity index. The incorporation of AmB was high and depended on the volumefraction of the disperse phase. These MEs did not reduce the viability of J774.A1macrophage-like cells for concentrations up to 25 μg/mL of AmB. Therefore, O/W MEsbased on propylene glycol esters of caprylic acid may be considered as suitable deliverysystems for AmB
机译:本论文致力于开发两种不同分子的创新口服给药系统。在第一部分中,制备了基于木聚糖和Eudragit®S-100的微粒(MPs),并用于包裹5-氨基水杨酸以用于结肠递送。木聚糖是从玉米芯中提取的,并根据其理化,流变和毒理学特性进行了表征。通过界面交联聚合和喷雾干燥制备聚合物MP,并对其形貌,平均尺寸和分布,热稳定性,结晶度,包封效率和体外药物释放进行表征,并通过两种方法制备了具有适当物理特性和令人满意的收率的MPs,尽管喷雾干燥系统显示出更高的热稳定性。通常,喷雾干燥的MP由于其热稳定性和其制备中所使用的无毒剂而将是优选的系统。但是,药物装载和释放需要优化。在本文的第二部分,将基于中链甘油三酸酯的水包油微乳液(O / W MEs)配制为两性霉素B(AmB)的药物载体和溶解度增强剂。使用亲水亲脂平衡值在9.7和14.4之间的表面活性剂混合物构建相图。无药物和载有药物的MEs分别呈现约80和120 nm左右的球形非聚集液滴,且多分散指数低。 AmB的掺入量很高,并且取决于分散相的体积分数。对于浓度高达25μg/ mL的AmB,这些ME不会降低J774.A1巨噬细胞样细胞的活力。因此,基于辛酸丙二醇酯的O / W ME可能被认为是适合AmB的递送系统

著录项

  • 作者

    Silva Acarilia Eduardo da;

  • 作者单位
  • 年度 2013
  • 总页数
  • 原文格式 PDF
  • 正文语种 por
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号